Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D01OUA
|
|||
Former ID |
DIB005013
|
|||
Drug Name |
TJN-598
|
|||
Synonyms |
Glomerulonephritis therapy, Tsumura
Click to Show/Hide
|
|||
Indication | Glomerulonephritis [ICD-11: 5D00.Y] | Terminated | [1] | |
Company |
Tsumura & Co
|
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Phosphodiesterase 4A (PDE4A) | Target Info | Inhibitor | [1] |
Phosphodiesterase 4B (PDE4B) | Target Info | Inhibitor | [1] | |
Phosphodiesterase 4D (PDE4D) | Target Info | Inhibitor | [1] | |
KEGG Pathway | Purine metabolism | |||
cAMP signaling pathway | ||||
Morphine addiction | ||||
NetPath Pathway | IL5 Signaling Pathway | |||
IL2 Signaling Pathway | ||||
Pathwhiz Pathway | Purine Metabolism | |||
Reactome | DARPP-32 events | |||
G alpha (s) signalling events | ||||
WikiPathways | G Protein Signaling Pathways | |||
Myometrial Relaxation and Contraction Pathways | ||||
Nuclear Receptors Meta-Pathway | ||||
Opioid Signalling | ||||
TSH signaling pathway |
References | Top | |||
---|---|---|---|---|
REF 1 | Effects of TJN-598, a new selective phosphodiesterase type IV inhibitor on anti-Thy1 nephritis in rats. Clin Exp Nephrol. 2011 Feb;15(1):14-24. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.